UK SMEs can apply for a share of up to £10 million to work on solving healthcare challenges in a clinical setting or a relevant late stage environment.
Programme: Innovate UK
Award: Share of up to £10 million
Opens: 6th Aug 2018
Closes: 3rd Oct 2018
Biomedical Catalyst supports the development of innovative healthcare products, technologies and processes. These can include:
The late stage award supports projects which test a well-developed concept. It should show its effectiveness in an environment that is relevant to the use of the product or process. A late stage project can include:
Innovate UK will support projects from any sector or discipline, including (but not limited to):
You should have prior credible research on your proposal, including a demonstration of validation in a relevant model system.
An SME business can:
You are able to apply for a second project to be funded e.g. you may already hold both an early stage and a late stage award. When the early stage project finishes, you may apply in this round for a late stage award to continue that specific programme of work while still holding your original late stage award.
You will be asked to provide evidence that you have enough resources to run 2 projects at the same time.
If you have research organisations in your consortium, they can share up to 50% of the total eligible project costs.
Large organisations are unable to be partners on any project in this competition.
Innovate UK expect projects to range in size from £200,000 to £4 million (total project costs).
Projects should last 12 to 36 months and must start before 1 July 2019.
Projects that are too early stage will not be funded.
Projects without sufficient validated prior research will not be funded.
Projects that are too close to market, or already at market will not be funded.
Read Dr Emma Richardson’s blog featuring more information regarding precision medicine and how we could help you with this competition.